NovoCure
NVCR
NVCR
360 hedge funds and large institutions have $17.2B invested in NovoCure in 2021 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 124 increasing their positions, 114 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
360
Holders Change
+34
Holders Change %
+10.43%
% of All Funds
6.28%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
78
Increased
124
Reduced
114
Closed
43
Calls
$775M
Puts
$246M
Net Calls
+$529M
Net Calls Change
+$354M
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.73B |
| 2 |
Wells Fargo
San Francisco,
California
|
$130M |
| 3 |
Morgan Stanley
New York
|
$191M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
$282M |
| 5 |
Two Sigma Investments
New York
|
$12.9M |
